Chronic Pain Virtual Reality Therapy Market Report 2026

The chronic pain virtual reality therapy market size has grown exponentially in recent years. It will grow from $4.58 billion in 2025 to $6.09 billion in 2026 at a compound annual growth rate (CAGR) of 32.9%. The growth in the historic period can be attributed to rising prevalence of chronic pain conditions, increasing limitations of opioid-based therapies, growing acceptance of digital therapeutics, expansion of rehabilitation centers, availability of consumer-grade vr devices.

The chronic pain virtual reality therapy market size is expected to see exponential growth in the next few years. It will grow to $18.82 billion in 2030 at a compound annual growth rate (CAGR) of 32.6%. The growth in the forecast period can be attributed to increasing demand for drug-free pain management solutions, rising investments in digital therapeutics, expansion of home-based pain therapy adoption, growing use of ai-driven therapy customization, increasing integration with telehealth platforms. Major trends in the forecast period include increasing adoption of immersive pain distraction therapies, rising use of vr-based cognitive behavioral programs, growing integration of remote pain management platforms, expansion of personalized vr therapy content, enhanced focus on non-pharmacological pain control.

The growing awareness and acceptance of virtual reality therapy are expected to drive the expansion of the chronic pain virtual reality therapy market. Virtual reality therapy uses immersive technology to create interactive environments for treatment and rehabilitation. Its increasing adoption is fueled by evidence of its effectiveness in reducing pain and anxiety, providing patients with a non-invasive, drug-free option that enhances treatment experiences and outcomes. Greater awareness promotes chronic pain VR therapy by familiarizing patients and clinicians with immersive treatment options, encouraging wider adoption. It also improves therapy engagement by demonstrating the benefits of VR interventions, supporting better pain management and overall patient well-being. For example, in July 2024, the U.S. Department of Veterans Affairs deployed approximately 3,500 VR headsets across more than 170 medical centers and outpatient clinics, tripling the number available for therapeutic use. This growing awareness and acceptance are therefore key drivers of market growth.

Leading companies in the chronic pain virtual reality therapy market are focusing on innovations like the immersive in-home therapy model to enhance patient access, improve long-term adherence, and deliver cost-effective, non-pharmacological pain management solutions. The immersive in-home therapy model allows patients to participate in structured, interactive VR-based pain management sessions from their homes. For instance, in May 2024, US-based medical technology company AppliedVR launched RelieVRx, an FDA-authorized, prescription-based in-home VR therapy program for workers’ compensation patients with chronic lower back pain. RelieVRx offers structured, skills-based sessions clinically designed to reduce pain intensity and its interference in daily life, supporting faster recovery, functional improvement, and return-to-work outcomes. This example highlights VR therapy’s growing role as a safe, effective, and scalable alternative to traditional pharmacological pain management.

In April 2023, US-based extended reality therapeutics company XRHealth Ltd. merged with Spain-based Amelia Virtual Care for an undisclosed amount. Through this merger, XRHealth aims to integrate Amelia’s clinician-focused VR software with its virtual treatment-room operations to build a scalable extended reality therapeutics platform. This platform will address physical rehabilitation, behavioral health, and pain management programs across multiple care settings, expanding access to chronic pain VR therapy solutions.

Major companies operating in the chronic pain virtual reality therapy market are XRHealth Inc., AppliedVR Inc., Mieron VR, HypnoVR, KindVR, Waya Health, Flowly, CUREosity, Healium, Shine VR, Neuro Rehab VR Inc., Broomx Technologies, SyncVR Medical, Newel Health, Rocket VR Health, Corpus VR, Verity Technologies Inc., Karuna Labs Inc., Meta Platforms Inc., MediVR Inc., Immersive Health Solutions Inc.

North America was the largest region in the chronic pain virtual reality therapy market in 2025. The regions covered in the chronic pain virtual reality therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chronic pain virtual reality therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the chronic pain virtual reality therapy market by increasing costs of imported VR hardware, wearable sensors, display systems, and specialized software components. Healthcare providers in North America and Europe are most affected due to reliance on imported immersive technology equipment, while Asia-Pacific experiences higher production and export costs. These tariffs are elevating therapy deployment expenses and slowing adoption in smaller clinics. However, they are also encouraging domestic VR manufacturing, regional software innovation, and the development of cost-effective subscription-based therapy models.

The chronic pain virtual reality therapy market research report is one of a series of new reports that provides chronic pain virtual reality therapy market statistics, including chronic pain virtual reality therapy industry global market size, regional shares, competitors with a chronic pain virtual reality therapy market share, detailed chronic pain virtual reality therapy market segments, market trends and opportunities, and any further data you may need to thrive in the chronic pain virtual reality therapy industry. This chronic pain virtual reality therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chronic pain virtual reality therapy involves the use of immersive virtual reality (VR) technologies as a non-pharmacological approach to manage and reduce chronic pain. It provides engaging, interactive, and distraction-based virtual environments that help lower pain perception, improve emotional well-being, and enhance overall quality of life. The therapy is primarily designed to complement traditional pain management strategies.

The key components of chronic pain virtual reality therapy include hardware, software, and services. Hardware encompasses the devices and equipment used to deliver immersive VR experiences aimed at alleviating chronic pain. The technologies employed include non-immersive, semi-immersive, and fully immersive virtual reality, and they are applied in settings such as hospitals, clinics, home care, and rehabilitation centers. The therapy serves various end-users, including adults, pediatric, and geriatric patients.

The chronic pain virtual reality therapy market consists of revenues earned by entities by providing services such as virtual reality (VR)-based pain distraction sessions, integrative wellness services, specialized pain management, relaxation and mindfulness training, guided physical rehabilitation programs, and customized virtual environments. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic pain virtual reality therapy market also includes sales of virtual reality (VR) headsets, haptic feedback devices, motion sensors, outcome reporting dashboards, and clinical workflow products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.